Solid chemical container and water treatment method
By using a water-insoluble film in the solid agent container, the problems of swelling and bridge formation of the agent are solved, and the long-term continuous dissolution of the agent and the improvement of the component residual rate are achieved.
Patent Information
- Application Number
- CN202380036058.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-05-13
- Filing Date
- 2023-02-06
- Publication Date
- 2024-12-03
AI Technical Summary
In the existing solid agent container, the water-soluble membrane dissolves due to moisture, causing the agent to swell and form a bridge. The method of preventing the bridge requires reducing the amount of the agent to fill or increasing complex structures.
A water-insoluble film is used between the solid agent layer. By synthesizing resin films such as polyethylene or polyvinyl chloride, the film area accounts for more than 1/2 of the horizontal section area of the storage space to prevent moisture from being transmitted to the upper side of the agent and inhibit the expansion of the agent. The formation of the bridge.
Effectively inhibit the swelling and formation of the drug substance, make the drug substance components last for a long time, and improve the residual rate and dissolution efficiency of the drug substance components.
Smart Images

Figure CN119072351A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a solid medicine container containing a water-soluble solid medicine, and more specifically, to a solid medicine container having a function of gradually dissolving the water-soluble solid medicine by contacting with the water to be treated and releasing it into the water to be treated. In addition, the present invention relates to a water treatment method for water treatment using the solid medicine container. Background Art
[0002] As a solid medicine container for gradually dissolving a water-soluble solid medicine into treated water, patent document 1 describes a solid medicine container, which has a storage space capable of accommodating a plurality of water-soluble solid medicines, an inlet for allowing treated water to flow into the storage space, and an outlet for allowing treated water to flow out of the storage space, wherein the water-soluble solid medicines are stacked in a vertical direction in the storage space via a water-soluble membrane, and at least a portion of the water-soluble membrane is arranged above the inlet and the outlet.
[0003] According to the solid medicine container, among the plurality of water-soluble solid medicines stored in the storage container, the medicine that is not exposed to the flow path of the treated water formed between the inlet and the outlet of the storage container can reduce the moisture content of the water-soluble solid medicine and improve the residual rate of the active ingredient of the medicine, compared with the case where the medicine is used under the same conditions except for the presence of the water-soluble film, even if the medicine directly below it is dissolving.
[0004] However, in the solid medicine container of Patent Document 1, the water-soluble film is dissolved by water (water vapor, water droplets, water rising due to capillary action, etc.), and the solid medicine on the upper side of the film absorbs water and swells, sometimes forming a bridge.
[0005] As a method for preventing bridges of solid medicines, Patent Document 2 describes a method for preventing bridges by placing a weight (drop cover) on the top of a solid medicine filled in a container, thereby pressing down the solid medicine with the weight of the weight. Patent Document 3 describes a solid medicine continuous automatic dissolution device as a device for continuous and automatic dissolution, which includes a solid medicine dissolution device having a perforated inclined surface.
[0006] Prior art literature
[0007] Patent Literature
[0008] Patent Document 1: Japanese Patent Application Publication No. 2018-167239
[0009] Patent Document 2: Japanese Patent Application Publication No. 2013-240778
[0010] Patent document 3: Japanese Patent Application Publication No. 2000-117263. Summary of the invention
[0011] Problems to be solved by the invention
[0012] In the technology described in Patent Document 1, there is a concern that the water-soluble film may be dissolved by moisture and the water-soluble solid drug on the upper side of the film may swell and form a bridge.
[0013] In order to prevent the bridge, when a sinker is set in the container, a space corresponding to the volume of the sinker is required, so the filling amount of the solid medicine must be reduced. In addition, when using a solid medicine dissolving device with a perforated inclined surface, in addition to the solid medicine filling tube, parts with complex shapes and structures are also required.
[0014] An object of the present invention is to provide a solid medicine container which suppresses the formation of bridges by solid medicines and is configured so that the entire amount of the solid medicines is gradually dissolved, and a water treatment method using the solid medicine container.
[0015] Means for solving problems
[0016] The solid medicine container of the present invention is a solid medicine container configured by stacking water-soluble solid medicines in a storage space of a storage container, wherein the storage container comprises: a storage space capable of accommodating a plurality of water-soluble solid medicines; an inlet for allowing water to flow into the storage space; and an outlet for allowing water to flow out of the storage space, and is characterized in that a water-insoluble film is interposed between the layers of the solid medicine.
[0017] In one embodiment of the present invention, the storage container comprises: a container body, which is formed by interlocking an upper component and a lower component; a partition wall, which divides the interior of the container body into the receiving space and the non-receiving space; a partition wall connecting path, which connects the receiving space and the non-receiving space so that water can flow between the receiving space and the non-receiving space, and functions as the inlet and outlet; and a container connecting path, which connects the inside and the outside of the storage container so that water can flow between the outside of the container body and the non-receiving space.
[0018] In one embodiment of the present invention, the water-insoluble film is a synthetic resin film.
[0019] In one embodiment of the present invention, the synthetic resin is polyethylene or polyvinyl chloride.
[0020] In one aspect of the present invention, the area of the film is at least 1 / 2 of the horizontal cross-sectional area of the housing space, and particularly preferably at least 80%.
[0021] The water treatment method of the present invention is a water treatment method for dissolving a solid agent in water to be treated and adding the agent, characterized in that the solid agent is dissolved by bringing the solid agent container of the present invention into contact with the water to be treated, thereby adding the agent to the water to be treated.
[0022] Effects of the Invention
[0023] In the solid medicine container of the present invention, a water-insoluble film is interposed between the layers of the solid medicine, thereby preventing moisture (water vapor, water droplets, rising water due to capillary phenomena, etc.) from being transferred to the solid medicine on the upper side of the film, thereby preventing the swelling of the solid medicine. As a result, the formation of bridges by the solid medicine can be prevented. Therefore, according to the solid medicine container of the present invention and the water treatment method using the solid medicine container, the components of the solid medicine can be dissolved in the treated water for a long time. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a perspective view schematically showing a storage container of one embodiment of a solid medicine container.
[0025] Figure 2 yes Figure 1 A longitudinal cross-sectional view of a solid medicine container is shown.
[0026] Figure 3 This is a schematic explanatory diagram of a filling state of a solid medicine container with a solid medicine.
[0027] Figure 4 It is an explanatory diagram of the dissolution state of the solid medicine in the solid medicine container. DETAILED DESCRIPTION
[0028] The present invention will be described in detail below. In the present embodiment, the case where the water to be treated is cooling water of a cooling tower is described, but the water to be treated may be other water such as circulating water of a swimming pool.
[0029] [Storage container]
[0030] The storage container of the solid medicine container of the present invention has: an inlet for allowing the treated water to flow into the container; and an outlet for allowing the treated water flowing into the container to flow out of the container. For example, the storage container has: a cylindrical portion; a top surface portion and a bottom surface portion that seal both ends of the cylindrical portion; an inlet provided on the cylindrical portion and / or the bottom surface portion; and an outlet provided on the cylindrical portion and / or the bottom surface portion. It should be noted that the inlet can also serve as an outlet.
[0031] Figure 1 is a perspective view showing an example of a storage container, Figure 2 The storage container 10 has a substantially cylindrical container body 11. Figure 2 As shown, the interior of the container body 11 is partitioned by a cylindrical partition wall 12 into a storage space 13 for storing a water-soluble solid medicine and a non-storage space 14 for not storing a water-soluble solid medicine.
[0032] <Container body 11>
[0033] The container body 11 is composed of an upper member 11a and a lower member 11b. The upper member 11a has a top 11t, a cylindrical hanging wall 11r hanging from the outer periphery of the top 11t, and a cylindrical partition wall 12 hanging from the top 11t. The hanging wall 11r and the partition wall 12 are coaxially arranged. The lower member 11b has a bottom surface 11f and a side peripheral surface 11s.
[0034] It should be noted that the hanging wall 11r, the partition wall 12 and the side peripheral surface 11s may be in shapes other than the cylindrical shape, for example, an elliptical cylinder, a polygonal cylinder with four or more sides or the like.
[0035] The upper member 11a and the lower member 11b are preferably separable and easily integrated (eg, fitted). In this embodiment, the hanging wall 11r of the upper member 11a and the upper portion of the side peripheral surface 11s of the lower member 11b are detachably fitted.
[0036] The top 11t of the upper member 11a is provided with a hole 15a as a container communication passage through which water can flow. The hole 15a is arranged between the partition wall 12 and the hanging wall 11r in the top 11t. The plurality of holes 15a are arranged at substantially equal intervals in the circumferential direction. Through the hole 15a, the non-containment space 14 is connected to the outside above the storage container 10.
[0037] Holes 15b serving as container communication paths through which water can flow are provided near the intersection of the side peripheral surface 11s and the bottom surface 11f of the lower member 11b. The plurality of holes 15b are arranged at substantially equal intervals in the circumferential direction.
[0038] The bottom surface 11f of the lower member 11b is provided with holes 15c as container communication paths through which water can flow. The plurality of holes 15c are arranged substantially evenly over the entire bottom surface 11f.
[0039] <Division wall 12>
[0040] The partition wall 12 is vertically provided from the top 11t of the upper member 11a. The inner side of the partition wall 12 is the storage space 13. The diameter (inner diameter) of the partition wall 12 is preferably 20 to 200 mm, and particularly preferably about 50 to 70 mm. When the partition wall 12 is non-cylindrical, the horizontal cross-sectional area of the storage space 13 is preferably 300 to 30,000 mm. 2 , particularly preferably 2000 to 4000 mm2 about.
[0041] The outer diameter of the partition wall 12 is smaller than the inner diameter of the side peripheral surface 11 s , and a non-accommodating space 14 is defined between the partition wall 12 and the side peripheral surface 11 s .
[0042] The gap between the lower end of the partition wall 12 and the bottom surface 11f of the lower member 11b opposite thereto forms a partition wall connecting passage 16 that connects the accommodation space 13 and the non-accommodation space 14. In this embodiment, the gap between the lower end of the partition wall 12 and the bottom surface 11f (the upper and lower widths of the partition wall connecting passage 16) is preferably 1 to 50 mm, and particularly preferably 3 to 10 mm.
[0043] In the present embodiment, the partition wall communication passage 16 functions as an "inflow port" and an "outflow port", and the holes (container communication passages) 15b and 15c function as an "outflow port".
[0044] It should be noted that the partition wall communication passage 16 is not particularly limited in shape, size, arrangement, and number as long as water can flow therethrough, and can be appropriately determined according to the desired flow rate of cooling water. The lower end of the partition wall can be in contact with the bottom surface of the container body opposite thereto, and the partition wall communication passage is formed in a manner that a water flow hole is provided in a portion between the partition wall and the bottom surface of the container body.
[0045] The storage container 10 of this embodiment is a transparent or translucent container made of synthetic resin such as polypropylene, and is configured so that the state of the water-soluble solid medicine inside the container can be easily visually observed from the outside of the container. The synthetic resin preferably has water resistance and chemical resistance.
[0046] [Water-soluble solid medicine]
[0047] The water-soluble solid chemical is not particularly limited, and examples thereof include solid chemicals that can be used as a water treatment agent for cooling water in a cooling tower.
[0048] The water-soluble solid agent that can be used as a water treatment agent for cooling water of a cooling tower is preferably a cooling water composite chemical containing phosphonic acid, azole copper anti-corrosion agent and calcium hydroxide, but it can also be solid chlorine-based oxidants such as calcium hypochlorite, trichloroisocyanuric acid, dichloroisocyanuric acid, chlorous acid, bromochloro-5,5-dimethylhydantoin (BCDMH) or other agents.
[0049] The water-soluble solid pharmaceutical preparation is preferably in the form of a round disc-shaped tablet.
[0050] The tablet preferably has a diameter of 5 to 100 mm, particularly preferably 10 to 30 mm, and a thickness of 1 to 50 mm, particularly preferably 10 to 20 mm.
[0051] The number of layers of tablets placed in the container is preferably 2 to 10, particularly preferably about 5 to 6.
[0052] [Water-insoluble film]
[0053] As the water-insoluble film, a film made of a water-insoluble and water-impermeable synthetic resin is suitable, but it may also be a metal, ceramic, etc. As the synthetic resin, polyethylene, polyvinyl chloride, etc. are suitable.
[0054] The thickness of the water-insoluble film made of synthetic resin is 1000 μm or less, for example, preferably about 10 to 100 μm. The shape of the water-insoluble film is not particularly limited and can be appropriately determined.
[0055] In the present invention, the area of the water-insoluble film can be more than 1 / 2 of the horizontal cross-sectional area of the receiving space 13 (the horizontal cross-sectional area in a state where the solid medicine receiving body is arranged in a manner that the axial direction of the partition wall becomes a vertical direction), preferably more than 80%, more preferably more than 85%, and particularly preferably more than 88%. It should be noted that if the film is too large, when the film is configured in the receiving space 13, the peripheral edge of the film overlaps with the inner peripheral surface of the partition wall 12, resulting in poor operability. In addition, when the film overlaps with the bottom surface of the container after the solid medicine is dissolved, there is a concern that the peripheral edge of the film will block the hole 15c on the bottom surface of the container. The area of the water-insoluble film can be, for example, less than 150%, less than 120%, or less than 100% of the horizontal cross-sectional area of the receiving space 13. The size of the film is particularly preferably less than the size of the horizontal cross-section of the receiving space 13.
[0056] [Filling method of solid medicine]
[0057] The process of filling the solid medicine composed of tablets into the storage space 13 is preferably performed as follows. That is, first, the upper member 11a and the lower member 11b are separated, and the upper member 11a is turned upside down so that the partition wall 12 is in a state of standing up from the top 11t. Then, a plurality of tablets are laid out on the top 11t. The tablets are laid out as much as possible so that they do not overlap each other and the side circumferences of the tablets are closely aligned or close to each other.
[0058] Next, a film (first film) is arranged to cover the layer of laid out tablets (first layer).
[0059] On top of the first film, the tablets are laid out in the same manner as above to form a second layer, and a film (second film) is stacked on the second layer, and the process is repeated. After the last layer of tablets is laid out, it is not necessary to stack a film on the last layer of tablets, and the upper member 11a and the lower member 11b are engaged and combined. Next, the upper member 11a is turned upside down so that the upper member 11a is on the upper side of the lower member 11b, thereby forming Figure 3 The solid medicine container shown. Figure 3 T indicates tablet, and F indicates water-insoluble film.
[0060] [Dissolution form of solid medicine in solid medicine container]
[0061] When the solid medicine container constructed as described above is arranged in the water falling area, Figure 3 As shown, water flows from hole 15a into non-accommodation space 14 of storage container 10 and accumulates at the bottom of storage container 10. The accumulated water W contacts the tablet T at the bottom layer, and the tablet T at the bottom layer gradually dissolves, so that the water containing the solid medicine flows downward from holes 15b and 15c.
[0062] As the dissolution of the tablet T at the bottom layer proceeds, the thickness of the bottom layer of the tablet decreases, and all the tablet layers on the upper side gradually move downward.
[0063] When the tablets T in the bottom layer are completely dissolved, the first film F from the bottom is overlapped on the bottom surface 11f of the lower member 11b, and then the tablets T in the tablet layer located second from the bottom when the tablets are new are dissolved.
[0064] Thereafter, the same procedure is performed to sequentially dissolve up to the uppermost tablet layer. Figure 4 It is shown that the third tablet layer has been dissolved out of the six tablet layers, leaving only three tablet layers.
[0065] In this embodiment, the water-insoluble film F is interposed between the tablet layers, and preferably the area of the water-insoluble film F is set to be 1 / 2 or more of the horizontal cross-sectional area of the storage space 13, so that moisture (water vapor, water droplets, rising water due to capillary phenomenon, etc.) from the water W in the container can be prevented from contacting the tablet T above the film F. Therefore, the tablet above the film F can be prevented from swelling, and the bridge of the solid medicine in the solid medicine storage body can be prevented. As a result, the medicine is continuously added to the treated water.
[0066] Example
[0067] [Example 1]
[0068] Will Figure 1 The solid medicine container shown was placed three times in a cooling tower of an open circulation cooling water system to observe whether bridges occurred. The main conditions are as follows.
[0069] <Container body 10>
[0070] The diameter (inner diameter) of the side peripheral surface 11s is 83.85 mm.
[0071] The distance between the side peripheral surface 11s and the partition wall 12 is 8.55 mm.
[0072] The inner diameter of the partition wall 12 is 60.78 mm.
[0073] Height of the partition wall 12: 61.0 mm.
[0074] The distance between the lower end of the partition wall 12 and the bottom surface 11f is 4.4 mm.
[0075] The diameter and number of holes 15a: 4.6 mm, 16 holes.
[0076] The diameter and number of holes 15b: 3.0 mm, 16 holes.
[0077] The diameter and number of holes 15c: 10.0 mm, 10 holes.
[0078] <Solid medicine>
[0079] Type: Phosphonic acid and azole copper resists.
[0080] Tablet diameter: 21.7 mm.
[0081] Thickness of tablet: 10.7 mm.
[0082] <Water-insoluble film>
[0083] Resin: Polyethylene.
[0084] Thickness: 0.04mm (40μm).
[0085] Diameter: 70%, 80%, 85%, 90%, 92%, 95%, 100%, 110% or 120% of the inner diameter of the partition wall 12 (as the ratio of the area of the water-insoluble film F to the horizontal cross-sectional area of the containing space 13 (hereinafter sometimes referred to as the "membrane area ratio"), 49%, 64%, 72%, 81%, 88%, 94%, 100%, 121%, 144%).
[0086] <Experimental methods>
[0087] The upper member 11a is removed from the lower member 11b, and five solid medicines T are arranged on the top 11t without overlapping each other, and a polyethylene film F is placed on top of the solid medicines. This is considered as one layer, and the process is repeated until a total of five layers are formed. Next, the upper member 11a and the lower member 11b are combined to form a solid medicine container.
[0088] The solid medicine container was evaluated for its solubility by an open circulating cooling water system at a water temperature of 30°C. That is, the solid medicine container was set above the filling material in a countercurrent type (circular) open cooling tower with a refrigeration capacity of 30 USRT and a 24h / day operation, and the solid medicine was dissolved by the circulating water sprinkled thereon.
[0089] The solid drug container was removed after three weeks to determine the presence or absence of a bridge.
[0090] <Results / Investigation>
[0091] Table 1 shows the results of observation on the bridge occurrence conditions.
[0092] Table 1: Evaluation results when polyethylene film is used as the spacer material
[0093] Membrane diameter ratio (%) Membrane area ratio (%) Is there a bridge? 70 49 △ 80 64 △ 85 72 △ 90 81 ○ 92 88 ◎ 95 94 ◎ 100 100 ◎ 110 121 ◎※ 120 144 ◎※
[0094] ◎: No bridge occurred.
[0095] △: Bridges rarely occur.
[0096] ○: The occurrence of bridges is rare.
[0097] As shown in Table 1, according to the present invention, the occurrence of bridges can be suppressed, and in particular, by setting the membrane area ratio to 88% or more, the occurrence of bridges can be sufficiently prevented.
[0098] It should be noted that, when the film area ratio is 121% or more, although no bridge occurs, folding and other operations are required when filling the container, so the workability is poor. In addition, the polyethylene film accumulated at the bottom of the container hinders the contact between the tablet and water. Therefore, it is considered that the size of the film is preferably less than the size of the horizontal section of the accommodation space 13.
[0099] [Comparative Example 1]
[0100] The experiment was conducted under the same conditions as in Example 1 except that a polyvinyl alcohol-based water-soluble film with a thickness of 0.05 mm (diameter of 100% of the inner diameter of the partition wall 12, membrane area ratio of 100%) was used as the membrane. As a result, bridges were generated in the solid drug storage body after three weeks. The evaluation result of the occurrence of bridges in Comparative Example 1 was △ as shown in Table 1. Although the occurrence of bridges was small, the bridge suppression effect of Comparative Example 1 was poor compared with the case in Example 1 where the membrane area ratio was 100% the same as that of Comparative Example 1 (evaluation result ◎: no bridges were generated).
[0101] [Comparative Example 2]
[0102] The experiment was conducted under the same conditions as in Example 1 except that no membrane was used. As a result, bridges were significantly generated after three weeks. Compared with all cases of Example 1 (membrane area ratio 49 to 144%), the bridge suppression effect in Comparative Example 2 was inferior.
[0103] Although the present invention has been described in detail using specific embodiments, it will be apparent to one skilled in the art that various modifications can be made without departing from the spirit and scope of the present invention.
[0104] This application is based on Japanese patent application No. 2022-079601 filed on May 13, 2022, the entire contents of which are incorporated herein by reference.
[0105] Explanation of symbols
[0106] 10: Storage container.
[0107] 11: Container body.
[0108] 11a: Upper member.
[0109] 11b: Lower member.
[0110] 12: Next door.
[0111] 13: Containment space.
[0112] 14: Non-containment space.
[0113] 15a, 15b, 15c: holes (container communication paths).
[0114] 16: Zoning wall connecting road.
[0115] F: Water-insoluble film.
[0116] T: Tablets of water-soluble solid medicine.
Claims
1. A solid medicine container, wherein a water-soluble solid medicine is stacked in a storage space of a storage container, wherein the storage container comprises: a storage space capable of storing a plurality of water-soluble solid medicines; an inlet for allowing water to flow into the storage space; and an outlet for allowing water to flow out of the storage space, wherein: A water-insoluble film is interposed between the layers of the solid pharmaceutical preparation.
2. The solid medicine container according to claim 1, wherein: The storage container has: The container body is formed by fitting the upper member and the lower member; A partition wall divides the interior of the container body into the receiving space and the non-receiving space; a partition wall connecting passage, connecting the receiving space and the non-receiving space, allowing water to flow between the receiving space and the non-receiving space, and functioning as the inlet and outlet; and The container communication passage communicates the inside and outside of the storage container, so that water can flow between the outside of the container body and the non-accommodation space.
3. The solid medicine container according to claim 1, wherein: The water-insoluble film is a synthetic resin film.
4. The solid medicine container according to claim 3, wherein: The synthetic resin is polyethylene or polyvinyl chloride.
5. The solid medicine container according to claim 1, wherein: The area of the film is equal to or greater than 1 / 2 of the horizontal cross-sectional area of the accommodation space.
6. The solid medicine container according to claim 1, wherein: The area of the film is at least 80% of the horizontal cross-sectional area of the accommodation space.
7. The solid medicine container according to claim 1, wherein: The water-soluble solid medicament is a tablet.
8. A water treatment method, which is a water treatment method in which a solid agent is dissolved in the water to be treated and then added, characterized in that: The solid medicine container according to any one of claims 1 to 7 is brought into contact with the water to be treated to dissolve the solid medicine, thereby adding the medicine to the water to be treated.
